Supernus Pharmaceuticals | SUPN - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Abbott USD 4.24B 117M 2025-12
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Canopy Growth CAD 19.96M 1.83M 2025-12
Cara Therapeutics USD 3.22M 859K 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Eisai JPY 75.89B 9.6B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Novo Nordisk DKK 14.8B 4.96B 2026-03
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 434.8M 39.7M 2026-03
Pfizer USD 4.51B 734M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03